Article Listing - Novo Nordisk files BLA for first recombinant treatment for FXIII in USA

BIO-MERIEUX NEEDS NEW FINANCE

17 February 1992

The major French producer of in vitro diagnostic products, Bio-Merieux, plans to become one of the ten world diagnostic market...

OUTLOOK FOR FRENCH PHARMA STOCKS

17 February 1992

Although pricing of pharmaceutical products in France has lately been more favorable, it remains undeniably difficult, according to Baring Securities'...

US MARKET FOR FLU TREATMENTS

17 February 1992

The proliferation of flu remedies currently appearing on US drugstore shelves is more a product of marketing than medical breakthroughs,...

US GENERIC DRUG MARKET TO 1995

17 February 1992

The US market for generic drugs will more than double from a value of $5.5 billion in 1991 to reach...

GENZYME PRODUCES CFTR PROTEIN VIA MILK

17 February 1992

Genzyme Corp has announced that its researchers have developed the first genetically-engineered mice to produce in their milk a membrane...

HAFSLUND NYCOMED 46% OPERATING PROFIT JUMP

17 February 1992

Norwegian company Haflsund Nycomed reported a massive 46% rise in total operating profits for 1991, reaching 1.58 billion Norwegian kroner...

US FDA BANS COPIED ZALCITABINE

17 February 1992

The US Food and Drug Administra-tion has banned the sale of an unauthorized copy of Hoffmann-La Roche's AIDS therapy Hivid...

BIOCRAFT SETS SIGHTS ON GENERIC CECLOR

17 February 1992

At least one competitor has set its sights on capturing some of the market which will be left exposed when...

US OTC DRUGMAKERS A TAKEOVER TARGET

17 February 1992

The value of over-the-counter medicine franchises will continue to rise and as a result smaller OTC drugmakers (such as Carter...

MOROCCO BANS GLAFENINE

10 February 1992

Morocco is the latest country to ban marketing of Roussel Uclaf's glafenine-based analgesic products Adalgur, Glifanan and Myantal. A...

Showing 94761-94770 of 95333 articles